More Clinuvel Pharmaceuticals Limited news
Clinuvel Pharmaceuticals LimitedASX: CUV

TGA grants Orphan Drug Designation for SCENESSE

Feb 10, 2016 at 8:19 PM EST · Issued by Clinuvel Pharmaceuticals Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST

On 6ix: 6ix.com/news/tga-grants-orphan-drug-designation-for-scenesse

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

Later from Clinuvel Pharmaceuticals

  • US FDA orphan designation received for cutaneous porphyriasFeb 11, 2016
  • Clinuvel brief on European commercialisationFeb 15, 2016
  • Clinuvel PlacementMar 14, 2016
  • Clinuvel accredits first European EPP expert centresMar 14, 2016
  • Clinuvel enters a joint venture with Biotech Lab SingaporeMar 30, 2016
All Clinuvel Pharmaceuticals news releases↗

Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.

Follow Clinuvel Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer